• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".作者对Mungmunpuntipantip等人就《四种不同新冠疫苗品牌免疫接种后报告的不良事件频率描述》的评论的回复
Drug Saf. 2022 Aug;45(8):925-926. doi: 10.1007/s40264-022-01207-x. Epub 2022 Jul 15.
2
Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".关于《四种不同新冠疫苗品牌免疫接种后报告的不良事件频率描述》的评论
Drug Saf. 2022 Aug;45(8):923. doi: 10.1007/s40264-022-01205-z. Epub 2022 Jul 15.
3
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
4
Reply to Çınar et al. Comment on "Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. 2022, , 874".回复 Çınar 等人对“Zamfir 等人。在 mRNA COVID-19 疫苗接种运动的背景下诊断出的血液系统恶性肿瘤：两例报告。2022 年，，874”的评论。
Medicina (Kaunas). 2022 Nov 1;58(11):1576. doi: 10.3390/medicina58111576.
5
Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit.回复：癌症手术后感染新冠病毒患者的新冠疫苗接种——蒙蒙蓬蒂潘蒂潘和维瓦尼特基特的通信
Ann Surg Oncol. 2023 Apr;30(4):2109-2110. doi: 10.1245/s10434-022-13087-7. Epub 2023 Jan 27.
6
Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.对Mungmunpuntipantip和Wiwanitkiton所著《1例以COVID-19疫苗接种后全身性I型干扰素反应为特征的溃疡性结肠炎复发病例》的回应之回应
Inflamm Bowel Dis. 2022 Aug 1;28(8):e113. doi: 10.1093/ibd/izac081.
7
Adverse events following COVID-19 vaccination: A systematic review and meta-analysis.COVID-19 疫苗接种后的不良反应：系统评价和荟萃分析。
Int Immunopharmacol. 2022 Aug;109:108906. doi: 10.1016/j.intimp.2022.108906. Epub 2022 May 30.
8
Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.疫苗不良事件自动报告系统中报告的与 2019 年冠状病毒病疫苗接种相关的不良事件。
J Korean Med Sci. 2021 May 3;36(17):e114. doi: 10.3346/jkms.2021.36.e114.
9
Adverse Events Following the First Dose of Immunization of COVID-19 Vaccine.接种 COVID-19 疫苗第一针后的不良反应。
J Nepal Health Res Counc. 2022 Jun 2;20(1):59-64. doi: 10.33314/jnhrc.v20i01.3810.
10
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.

引用本文的文献

1
Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".关于《四种不同新冠疫苗品牌免疫接种后报告的不良事件频率描述》的评论
Drug Saf. 2022 Aug;45(8):923. doi: 10.1007/s40264-022-01205-z. Epub 2022 Jul 15.

Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".

作者信息

Kant Agnes, van Hunsel Florence

机构信息

Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's Hertogenbosch, The Netherlands.

出版信息

Drug Saf. 2022 Aug;45(8):925-926. doi: 10.1007/s40264-022-01207-x. Epub 2022 Jul 15.

DOI:10.1007/s40264-022-01207-x
PMID:35838877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9284101/
Abstract
摘要